| http://www.w3.org/ns/prov#value | - Rx Product NewsHOT RxSymbicortMarketed by:AstraZeneca (Wilmington, DE)Indication:AstraZeneca announced FDA approval of Symbicort (budesonide/ formoterol fumarate dihydrate) 160/4.5 mcg for the twice-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.
|
